[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:chronic-granulomatous-disease":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":80,"states":81},"Chronic Granulomatous Disease",11,8,[8,16,23,29,36,42,48,54,60,67,73],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT05463133","Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease (CGD) With an Alemtuzumab, Busulfan and TBI-based Conditioning Regimen Combined With Cytokine (IL-6, +\u002F- IFN-gamma) Antagonists",[12],"Phase 1\u002FPhase 2","RECRUITING","2026-08-26T02:16:04.914942Z","2026-05-05T02:43:29.194582Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT05189925","NADPH Oxidase Correction in mRNA-transfected Granulocyte-enriched Cells in Chronic Granulomatous Disease (CGD)",[20],"Phase 1","2026-08-26T02:18:04.640417Z","2026-05-05T02:43:27.856369Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":27,"content_modified":28},"NCT03167437","An Open-Label, Proof of Consent Study of Vorinostat for the Treatment of Mdoerate-to-Severe Crohn s Disease and Maintenance Therapy With Ustekinumab",[12],"2026-08-26T02:18:58.958025Z","2026-05-05T02:43:28.983405Z",{"nct_id":30,"title":31,"phases":32,"status":13,"updated_at":34,"content_modified":35},"NCT07284641","Hematopoietic Stem Cell Transplantation (HSCT) for Common Variable Immunodeficiency (CVID) and Other Autoimmune Manifestations of Primary Immune Regulatory Disorders (PIRD)",[33],"Phase 2","2026-08-26T02:17:02.694423Z","2026-05-05T02:43:28.474885Z",{"nct_id":37,"title":38,"phases":39,"status":13,"updated_at":40,"content_modified":41},"NCT06605378","Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease",[],"2026-08-26T02:17:05.172421Z","2026-05-13T02:55:06.554315Z",{"nct_id":43,"title":44,"phases":45,"status":13,"updated_at":46,"content_modified":47},"NCT00001405","Recruitment and Apheresis Collection of Peripheral Blood Hematopoietic Stem Cells, Mononuclear Cells and Granulocytes",[],"2026-08-26T02:17:51.502023Z","2026-07-05T18:42:10.721265Z",{"nct_id":49,"title":50,"phases":51,"status":13,"updated_at":52,"content_modified":53},"NCT04528355","Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC",[],"2026-08-26T02:16:24.970704Z","2026-05-13T02:55:06.255132Z",{"nct_id":55,"title":56,"phases":57,"status":13,"updated_at":58,"content_modified":59},"NCT00128973","Evaluation of Patients With Immune Function Abnormalities",[],"2026-08-26T02:16:54.876240Z","2026-05-13T02:55:06.032743Z",{"nct_id":61,"title":62,"phases":63,"status":64,"updated_at":65,"content_modified":66},"NCT06253507","pCCLCHIM-p47 (Lentiviral Vector Transduced CD34 Plus Cells) in Patients With p47 Autosomal Recessive Chronic Granulomatous Disease (AR-CGD)",[12],"ENROLLING_BY_INVITATION","2026-08-26T02:19:13.549512Z","2026-06-16T05:54:07.722593Z",{"nct_id":68,"title":69,"phases":70,"status":64,"updated_at":71,"content_modified":72},"NCT01852370","Sequential Cadaveric Lung and Bone Marrow Transplant for Immune Deficiency Diseases",[12],"2026-08-26T02:17:44.240289Z","2026-06-16T05:54:07.951235Z",{"nct_id":74,"title":75,"phases":76,"status":77,"updated_at":78,"content_modified":79},"NCT03655223","Early Check: Expanded Screening in Newborns",[],"ACTIVE_NOT_RECRUITING","2026-08-03T03:53:57.297126Z","2026-06-16T05:54:07.977837Z",[],[82,86],{"state":83,"count":84,"slug":85},"Maryland",7,"maryland",{"state":87,"count":88,"slug":89},"Pennsylvania",4,"pennsylvania"]